Taurine prevents the neurotoxicity of β-amyloid and glutamate receptor agonists: Activation of GABA receptors and possible implications for Alzheimer's disease and other neurological disorders

FASEB Journal

Volumn 18, Issue 3, 2004, Pages 511-518

  Louzada, Paulo Roberto ^a   Paula Lima, Andréa C ^a   Mendonça Silva, Dayde L ^a   Noël, François ^a   De Mello, Fernando G ^a   Ferreira, Sérgio T ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

Amyloid; Neuroprotection

Indexed keywords

4 AMINOBUTYRIC ACID; 4 AMINOBUTYRIC ACID A RECEPTOR BLOCKING AGENT; 4 AMINOBUTYRIC ACID A RECEPTOR STIMULATING AGENT; 4 AMINOBUTYRIC ACID RECEPTOR; AMYLOID BETA PROTEIN; BETA AMINO ACID; GLUTAMATE RECEPTOR; GLUTAMATE RECEPTOR AGONIST; LIGAND; MELATONIN; PHENOBARBITAL; PICROTOXIN; TAURINE;

ALZHEIMER DISEASE; ANIMAL CELL; ARTICLE; BRAIN DISEASE; BRAIN PROTECTION; CHICK EMBRYO; CONTROLLED STUDY; EMBRYO; EXCITOTOXICITY; GABAERGIC TRANSMISSION; GLUTAMATERGIC TRANSMISSION; ISOTOPE LABELING; LIGAND BINDING; NERVE CELL LESION; NEUROTOXICITY; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; RECEPTOR BINDING; RETINA NERVE CELL; THERAPY;

ALPHA-AMINO-3-HYDROXY-5-METHYL-4-ISOXAZOLEPROPIONIC ACID; ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; CELL AGING; CELLS, CULTURED; CHICK EMBRYO; DIZOCILPINE MALEATE; EXCITATORY AMINO ACID AGONISTS; EYE PROTEINS; GLUTAMIC ACID; KAINIC ACID; N-METHYLASPARTATE; NEURONS; NEUROPROTECTIVE AGENTS; PICROTOXIN; RECEPTORS, AMPA; RECEPTORS, GABA; RECEPTORS, GABA-A; RECEPTORS, GLUTAMATE; RECEPTORS, N-METHYL-D-ASPARTATE; RETINA; TAURINE;

ANIMALIA;

EID: 1542313858     PISSN: 08926638     EISSN: None     Source Type: Journal    
DOI: 10.1096/fj.03-0739com     Document Type: Article

References (57)

1. Lipton, S. A., and Rosenberg, P. A. (1994) Excitatory amino acids as a final common pathway for neurologic disorders. N. Engl. J. Med. 330, 613-622
2. Mattson, M. (2003) Excitotoxic and excitoprotective mechanisms: abundant targets for the prevention and treatment of neurodegenerative disorders. Neuromolec. Med. 3, 65-94
3. Gasic, G. P., and Hollmann, M. (1992) Molecular neurobiology of glutamate receptors. Annu. Rev. Physiol. 54, 507-536
4. Behrens, P. F., Franz, P., Woodman, B., Lindenberg, K. S., and Landwehrmeyer, G. B. (2002) Impaired glutamate transport and glutamate-glutamine cycling: downstream effects of the Huntington mutation. Brain 125, 1908-1922
5. Cluskey, S., and Ramsden, D. B. (2001) Mechanisms of neurodegeneration in amyotrophic lateral sclerosis. J. Clin. Pathol. 54, 386-392
6. Kieburtz, K. D., Epstein, L. G., Gelbard, H. A., and Greenamyre, J. T. (1991) Excitotoxicity and dopaminergic dysfunction in the acquired immunodeficiency syndrome dementia complex. Therapeutic implications. Arch. Neurol. 48, 1281-1284
7. Difazio, M. C., Hollingsworth, Z., Young, A. B., and Penney, J. B., Jr. (1992) Glutamate receptors in the substantia nigra of Parkinson's disease brains. Neurology 42, 402-406
8. Selkoe, D. J. (1999) Translating cell biology into therapeutic advances in Alzheimer's disease. Nature (London) 399, A23-A31
9. Pike, C. J., Walencewicks, A. J., Glabe, C. G., and Cotman, C. W. (1991) In vitro aging of β-amyloid causes peptide aggregation and neurotoxicity. Brain Res. 563, 311-314
10. Kowall, N. W., McKee, A. C., Yankner, B. A., and Beal, M. F. (1992) In vivo neurotoxicity of β-amyloid [β (1-40)] and the β (25-35) fragment. Neurobiol. Aging 13, 537-542
11. Mattson, M. P., Cheng, B., Davis, D., Bryant, K., Lieberburg, I., and Ryde, R. E. (1992) β-Amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity. J. Neurosci. 12, 376-389
12. +-dependent glutamate uptake. Life Sci. 650, 1977-1981
13. Arias, C., Arrieta, I., and Tapia, R. (1995) β-Amyloid peptide fragment 25-35 potentiates the calcium-dependent release of excitatory amino acids from depolarized hippocampal slices. J. Neurosci. Res. 41, 561-566
14. Noda, N., Nakanishi, H., and Akaike, N. (1999) Glutamate release from microglia via glutamate transporter is enhanced by amyloid-beta peptide. Neuroscience 92, 1465-1474
15. Harkany, T., Abraham, I., Timmerman, W., Laskay, G., Toth, B., Sasvari, M., Konya, C., Sebens, J. B., Korf, J., Kyakas, C., et al. (2000) β-Amyloid neurotoxicity is mediated by a glutamate-triggered excitotoxic cascade in rat nucleus basalis. Eur. J. Neurosci. 12, 2735-2745
16. Louzada, P. R., Lima, A. C. P., Mello, F. G., and Ferreira, S. T. (2001) Dual role of glutamatergic transmission on amyloid β1-42 aggregation and neurotoxicity in embryonic avian retina. Neurosci. Lett. 301, 59-63
17. Guidotti, A., Badiani, G., and Pepeu, G. (1972) Taurine distribution in cat brain. J. Neurochem. 19, 431-435
18. Okamoto, K., Kimura, H., and Sakai, Y. (1983) Taurine-induced increase of the Cl-conductance of cerebellar Purkinje cell dendrites in vitro. Brain Res. 259, 319-323
19. del Olmo, N., Bustamante, J., del Río, R. M., and Solis, J. M. (2000) Taurine activates GABA(A) but not GABA(B) receptors in rat hippocampal CA1 area. Brain Res. 864, 298-307
20. Alvarez, A., Alarcón, R., Opazo, C., Campos, E. O., Muñoz, F. J., Calderón, F. H., Dajas, F., Gentry, M. K., Doctor, B. P., Mello, F. G., et al. (1998) Stable complexes involving acetylcholinesterase and amyloid-β peptide change the biochemical properties of the enzyme and increase the neurotoxicity of Alzheimer's fibrils. J. Neurosci. 18, 3213-3223
21. De Felice, F. G., Houzel, J. C., Garcia-Abreu, J., Louzada, P. R., Jr., Afonso, R. C., Meirelles, M. N., Neto, V. M., and Ferreira, S. T. (2001) Inhibition of Alzheimer's disease beta-amyloid aggregation, neurotoxicity, and in vivo deposition by nitrophenols: implications for Alzheimer's therapy. FASEB J. 7, 1297-1299
22. Bradford, M. M. (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72, 248-254
23. Johnston, G. A., Lodge, D., Bornstein, J. C., and Curtis, D. R. (1980) Potentiation of L-glutamate and L-aspartate excitation of cat spinal neurones by the stereoisomers of threo-3 hydroxyaspartate. J. Neurochem. 34, 241-243
24. Nagelhus, E. A., Lehmann, A., and Ottersen, O. P. (1993) Neuronal-glial exchange of taurine during hypo-osmotic stress: a combined immunocytochemical and biochemical analysis in rat cerebellar cortex. Neuroscience 54, 615-631
25. Mc Bride, W. J., and Frederickson, R. C. (1980) Taurine as a possible inhibitory transmitter in the cerebellum. Federation Proc. 39, 2701-2705
26. Zhao, P., Huang, Y. L., and Cheng, J. S. (1999) Taurine antagonizes calcium overload induced by glutamate or chemical hypoxia in cultured rat hippocampal neurons. Neurosci. Lett. 268, 25-28
27. El Idrissi, A., and Trenkner, E. (1999) Growth factors and taurine protect against excitotoxicity by stabilizing calcium homeostasis and energy metabolism. J. Neurosci. 19, 9459-9468
28. Lima, L., Matus, P., and Drujan, B. (1993) Taurine-induced regeneration of goldfish retina in culture may involve a calcium mediated mechanism. J. Neurochem. 60, 2153-2158
29. Lima, L., and Cubillos, S. (1998) Taurine might be acting as a trophic factor in the retina by modulating phosphorylation of cellular proteins. J. Neurosci. Res 53, 377-384
30. Lombardini, J. B., and Props, C. (1996) Effects of kinase inhibitors and taurine analogues on the phosphorylation of specific proteins in mitochondrial fractions of rat heart and retina. Adv. Exp. Med. Biol. 403, 343-350
31. Saransaari, P., and Oja, S. S. (1997) Enhanced taurine release in cell-damaging conditions in the developing and ageing mouse hippocampus. Neuroscience 79, 847-854
32. Mills, C. D., Johnson, K. M., and Hulsebosch, C. E. (2001) Role of group II and group III metabotropic glutamate receptors in spinal cord injury. Exp. Neurol. 173, 153-167
33. Loureiro-Dos-Santos, N. E., Reis, R. A., Kubrusly, R. C., de Almeida, O. M., Gardino, P. F., de Mello, M. C., and de Mello, F. G. (2001) Inhibition of choline acetyltransferase by excitatory amino acids as a possible mechanism for cholinergic dysfunction in the central nervous system. J. Neurochem. 77, 1136-1144
34. Ikonomidou, C., Stefovska, V., and Turski, L. (2000) Neuronal death enhanced by N-methyl-D-aspartate antagonists. Proc. Natl. Acad. Sci. USA 97, 12885-12890
35. Fix, A. S., Horn, J. W., Wightman, K. A., Johnson, C. A., Long, G. G., Storts, R. W., Farber, N., Wozniak, D. F., and Olney, J. W. (1993) Neuronal vacuolization and necrosis induced by the noncompetitive N-methyl-D-aspartate (NMDA) antagonist MK(+)801 (dizocilpine maleate): a light and electron microscopic evaluation of the rat retrosplenial cortex. Exp. Neurol. 123, 204-215
36. Jevtovic-Todorovic, V., Wozniak, D. F., Powell, S., and Olney, J. W. (2001) Propofol and sodium thiopental protect against MK-801-induced neuronal necrosis in the posterior cingulate/retrosplenial cortex. Brain Res. 913, 185-189
37. Balla, A., Koneru, R., Smiley, J., Sershen, H., and Javitt, D. C. (2001) Continuous phencyclidine treatment induces schizophrenia-like hyperreactivity of striatal dopamine release. Neuropsychopharmacology 25, 157-164
38. Abel, K. M., Allin, M. P. G., Hemsley, D. R., and Geyer, M. A. (2003) Low dose ketamine increases prepulse inhibition in health men. Neuropharmacology 44, 729-737
39. Holden, C. (2003) Excited by glutamate. Science 300, 1866-1868
40. Keller, J. N., Mark, R. J., Bruce, A. J., Blanc, E., Rothstein, J. D., Uchida, K., Waeg, G., and Mattson, M. P. (1997) 4-Hydroxynonenal, an aldehydic product of membrane lipid peroxidation, impairs glutamate transport and mitochondrial function in synaptosomes. Neuroscience 80, 685-696
41. Butterfield, A. D., Castegna, A., Lauderback, M., and Drake, J. (2002) Evidence that amyloid beta-peptide-induced lipid peroxidation and its sequelae in Alzheimer's disease brain contribute to neuronal death. Neurobiol. Aging 23, 655-664
42. Tadolini, B., Pintus, G., Pinna, G. G., Bennardini, F., and Franconi, F. (1995) Effects of taurine and hypotaurine on lipid peroxidation. Biochem. Biophys. Res. Commun. 213, 820-826
43. Paula Lima, A. C., Louzada, P. R., Mello, F. G., and Ferreira, S. T. (2003) Neuroprotection against Aβ and glutamate toxicity by melatonin: are GABA receptors involved? Neurotox. Res. 5, 323-328
44. Forloni, G., Lucca, E., Angeretti, N., Chiesa, R., and Vezzani, A. (1997) Neuroprotective effect of somatostatin on nonapoptotic NMDA-induced neuronal death: role of cyclic GMP. J. Neurochem. 68, 319-327
45. Velasco, I., and Tapia, R. (2002) High extracellular gamma-aminobutyric acid protects cultured neurons against damage induced by the accumulation of endogenous extracellular glutamate. J. Neurosci. Res. 67, 406-410
46. Green, A. R., Hainsworth, A. H., and Jackson, D. M. (2000) GABA potentiation: a logical pharmacological approach for the treatment of acute ischaemic stroke. Neuropharmacology 39, 1483-1494
47. Schwartz-Bloom, R. D., Miller, K. A., Evenson, D. A., Crain, B. J., and Nadler, J. V. (2000) Benzodiazepines protect hippocampal neurons from degeneration after transient cerebral ischemia: an ultrastructural study. Neuroscience 98, 471-484
48. Frandsen, A., Quistorff, B., and Schousboe, A. (1990) Phenobarbital protects cerebral cortex neurones against toxicity induced by kainate but not by other excitatory amino acids. Neurosci. Lett. 111, 233-238
49. 2+ deregulation, and cytoskeletal pathology. Neurobiol. Aging 16, 187-198
50. Birdsall, T. C. (1998) Therapeutic applications of taurine. Altern. Med. Rev. 3, 128-136
51. Matsuyama, Y., Morita, T., Higuchi, M., and Tisujii, T. (1983) The effect of taurine administration on patients with acute hepatitis. Prog. Clin. Biol. Res. 125, 461-468
52. Benrabh, H., Bourre, J. M., and Lefauconnier, J. M. (1995) Taurine transport at the blood-brain barrier: an in vivo brain perfusion study. Brain Res. 692, 57-65
53. 3H brain barrier. Biochem. Pharmacol. 50, 1783-1793
54. Hassel, B., Tauboll, E., and Gjerstad, L. (2001) Chronic lamotrigine treatment increases rat hippocampal GABA shunt activity and elevates cerebral taurine levels. Epilepsy Res. 43, 153-163
55. Rodrigues, C. M. P., Solá, S., Brito, M. A., Brondino, C. D., Brites, D., and Moura, J. J. G. (2001) Amyloid beta-peptide disrupts mitochondrial membrane lipid and protein structure: protective role of tauroursodeoxycholate. Biochem. Biophys. Res. Commun. 281, 468-474
56. A subclass of GABA receptors. J. Neurochem. 74, 2087-2093
57. Pomara, N., Rajkumar Singh, M. D., Deptula, D., Chou, J. C. Y., Schwartz, M. B., and LeWitt, P. A. (1992) Glutamate and other CSF amino acids in Alzheimer's disease. Am. J. Psychiatry 149, 251-254